Key points from article :
A new report suggests that a blood test designed for people over 40, which checks for 200 types of diseases including common cancers, could significantly benefit the UK economy.
The report, commissioned by Randox, the UK's largest diagnostics firm, proposes that adopting these tests on the NHS could save about £12 billion annually by detecting diseases earlier. This comprehensive health check would cost roughly £230 per person, leading to an annual expense of £650 million for the NHS but promising substantial economic returns, including £11.7 billion in benefits over 16 years.
The study, conducted by OCO Global, highlights the potential for earlier disease detection and cost savings, drawing comparisons to health screening practices in Japan and South Korea, where such checks have proven effective.
Critics caution against potential overdiagnosis and unnecessary treatments resulting from extensive screening. The research underscores the increasing demand for preventative health measures amid growing NHS pressures and a rising number of health conditions expected by 2040.
Currently, the NHS offers limited health checks, focusing mainly on blood pressure and cholesterol, but the proposed test could provide a more detailed analysis.
The study also mentions the ongoing Galleri trial, which is testing a "liquid biopsy" for detecting multiple cancers and could further enhance early diagnosis efforts. A government spokesperson emphasised a commitment to improving early diagnosis and prevention, including plans to double diagnostic scanners to expedite the process.
